15 -5 (67) 2024 - Askerov A.A., Tashmamatova D.M. - MATERNAL FACTOR IN THE DEVELOPMENT OF PREGNANCY PATHOLOGY

MATERNAL FACTOR IN THE DEVELOPMENT OF PREGNANCY PATHOLOGY

Askerov A.A. Kyrgyz association of obstetrician-gynecologists and neonatologists. Kyrgyzstan, Bishkek, Clinik “ Institute of maternity” Bishkek city, Osh and Chui regional maternity hospitals.

Tashmamatova D.M. Kyrgyz association of obstetrician-gynecologists and neonatologists. Kyrgyzstan, Bishkek, Clinik “ Institute of maternity” Bishkek city, Osh and Chui regional maternity hospitals.

Karybekova A.M. Kyrgyz association of obstetrician-gynecologists and neonatologists. Kyrgyzstan, Bishkek, Clinik “ Institute of maternity” Bishkek city, Osh and Chui regional maternity hospitals.

Subanova G.A. Kyrgyz association of obstetrician-gynecologists and neonatologists. Kyrgyzstan, Bishkek, Clinik “ Institute of maternity” Bishkek city, Osh and Chui regional maternity hospitals.

Jalieva G.K. Kyrgyz association of obstetrician-gynecologists and neonatologists. Kyrgyzstan, Bishkek, Clinik “ Institute of maternity” Bishkek city, Osh and Chui regional maternity hospitals.

Amanatov B.K. Kyrgyz association of obstetrician-gynecologists and neonatologists. Kyrgyzstan, Bishkek, Clinik “ Institute of maternity” Bishkek city, Osh and Chui regional maternity hospitals.

Resume

The article consider and discusses the available foreign and domestic literature data on the role of folate in physiological and pathlogical processes, as well as some prospekts for its study and practical clinical applications. Conclusions. sufficient micronutrient provision of a woman’s body allows her to avoid many complications of pregnancy that negatively affect the health of the mother and fetus, including microvascular pathology.

Keywords: pregnancy complications, hyperhomocysteinemia, hypercoagulation, thrombophilia, folate.

First page

85

Last page

91

For citation: Askerov A.A., Tashmamatova D.M., Karybekova A.M., Subanova G.A., Jalieva G.K., Amanatov B.K. - MATERNAL FACTOR IN THE DEVELOPMENT OF PREGNANCY PATHOLOGY//New Day in Medicine 5(67)2024 85-91 https://newdayworldmedicine.com/en/article/3758

List of References

  1. Белобородова Е.В., Бицадзе В.О., Баймурадова С.М. Гипергомоцистинемия и осложненное течение беременности. РМЖ. 2006;44-48.
  2. L. D. Botto, Q. Yang «Варианты гена 5,10-метилентетрагидрофолатредуктазы (MTHFR) и врожденные аномалии: большой обзор», // Американский журнал эпидемиологии, 2000; 151(9): 862-877.
  3. Лоренцо Д. Ботто и Ян Цюаньхэ. Мутация гена MTHFR- C677T и двукратное увеличение риска врожденных пороков развития (центральной) нервной системы. // Американский журнал эпидемиологии. 2000;151(9).
  4. S.J. James, M. Pogribna, I.P. Pogribny, S. Melnyk, R.J. Hine, Gibson JB, P. Yi, D.L. Tafoya, D.H. Swenson, V.L. Wilson, D.W. Gaylor «Аномальный метаболизм фолата и мутации гена MTHFR у матерей – возможные факторы риска рождения ребенка с синдромом Дауна» // Американский журнал клинического питания. 2011;70(4):495-501.
  5. Hoţoleanu C, Chouky E. и др. Гипергомоцистеинемия и полиморфизм гена метилентетрагидрофолатредуктазы у пациентки с ишемической болезнью сердца и привычными выкидышами. // J Intern Med. 2012 Oct-Dec;50(4):313-6.

    file

    download